Merck Cash Flow from Investing Activities 2010-2024 | MKKGY
Merck annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
- Merck cash flow from investing activities for the quarter ending June 30, 2024 was $-0.774B, a 34.91% decline year-over-year.
- Merck cash flow from investing activities for the twelve months ending June 30, 2024 was $-5.138B, a 35.09% decline year-over-year.
- Merck annual cash flow from investing activities for 2023 was $-2.048B, a 29.15% decline from 2022.
- Merck annual cash flow from investing activities for 2022 was $-2.89B, a 54.8% increase from 2021.
- Merck annual cash flow from investing activities for 2021 was $-1.867B, a 21.97% increase from 2020.
Merck Annual Cash Flow Investing
(Millions of US $) |
| 2023 |
$-2,048 |
| 2022 |
$-2,890 |
| 2021 |
$-1,867 |
| 2020 |
$-1,531 |
| 2019 |
$-6,891 |
| 2018 |
$2,588 |
| 2017 |
$-1,296 |
| 2016 |
$-557 |
| 2015 |
$-13,245 |
| 2014 |
$-2,182 |
| 2013 |
$-1,162 |
| 2012 |
$-1,489 |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.254B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
